# EDGAR Filing Document

**Accession Number:** 0000849146
**File Stem:** 0000000000-26-002659
**Filing Date:** 2026-3
**Character Count:** 2457
**Document Hash:** 94de6bc1006cb95fe3b75b8ba6782686
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-26-002659.hdr.sgml**: 20260521

**ACCESSION NUMBER**: 0000000000-26-002659

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260316

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lifevantage Corp
- **CENTRAL INDEX KEY:** 0000849146
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 900224471
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-294183

**BUSINESS ADDRESS:**
- **STREET 1:** 3300 TRIUMPH BLVD
- **STREET 2:** SUITE 700
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043
- **BUSINESS PHONE:** 801-432-9000

**MAIL ADDRESS:**
- **STREET 1:** 3300 TRIUMPH BLVD
- **STREET 2:** SUITE 700
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LIFELINE THERAPEUTICS, INC.
- **DATE OF NAME CHANGE:** 20041019

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** YAAK RIVER RESOURCES INC
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ANDRAPLEX CORP
- **DATE OF NAME CHANGE:** 19920406
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001628280-26-016466

## Text-Extract

```

                                                           March 16, 2026

Steven Fife
Chief Executive Officer
LifeVantage Corporation
3300 Triumph Blvd., Suite 700
Lehi, UT 84043

       Re: LifeVantage Corporation
           Registration Statement on Form S-3
           Filed March 10, 2026
           File No. 333-294183
Dear Steven Fife:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Tyler Howes at 202-551-3370 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Life
Sciences
cc:    Kirt W Shuldberg, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._